MARKET

The Israel Institute of Biological Research vaccine, being developed by NRx Pharmaceuticals, has yet to be proved effective in the real world.

The company said that the move to the new factory will increase production to meet growing demand and improve the productivity of its employees.

The Israeli cryptocurrency security company for banks and financial institutions has nearly quadrupled its valuation since last June.

Israeli company Nurami Medical has recruited all the patients for a clinical trial on its product to repair soft tissue damaged during neurosurgery.

The Israeli currency is trading at levels against the US currency not seen since October 2021.

The Israeli company has promised a revolution in medical imaging but its market cap has slumped from $3.5 billion to $560 million, as investors begin to doubt whether it can deliver.

The Homepage For You platform complements existing ability to edit news homepages with a new AI layer that presents content readers might find more relevant.

Dudi Reznik of Leumi Capital Markets finds reasons to be cheerful; IBI's Rafi Gozlan is less optimistic.

Elbit Systems will provide the Weizmann Institute with the telescope as part of Israel’s Ultraviolet Transient Astronomy Satellite (ULTRASAT) program to observe and research deep space.

Tamares Telecom will be the project's anchor customer and provide initial finance.

GES will pay NIS 195 million for a 75% stake in the waste recycling company.

Non-bank credit companies will be able to issue bonds to finance housing loans.

The study met its primary endpoint, demonstrating that patients treated with EscharEx had a statistically significant higher incidence of complete debridement.

The Israeli currency continues to depreciate amid steep falls on stock markets worldwide.

The new price will be $4.5 per million British thermal units (mmBtu).

The steepest declines among the "2021 vintage" are in companies that went public through SPACs.

The Israeli fintech company has rescued payment solutions company OTI from insolvency proceedings.

Abercohen will leave his post at the head of Israel's largest supermarket chain on March 31st.

Large negative arbitrage gaps in dual-listed stocks are weighing on the Tel Aviv indices, with local bank stocks also falling heavily.

In the Covid pandemic, Israeli company Sonovia has become known for its superior facemasks, but its technology and ambitions go far beyond that.

Leader Capital Markets chief economist Yonatan Katz expects a rate hike in April, predicting that inflation will climb towards 3% annually.

Timora, which acquires, improves and manages investments in office, industrial, and logistical real estate in Israel, plans to increase its equity to NIS 500 million over the coming year.

Oppenheimer Israel senior equity analyst Sergei Vastchenok explains why Israeli tech stocks are struggling, as the market looks beyond Covid.

The Tel Aviv company's AI financial-data-driven personalization solutions for banks and financial services providers, enables them to target the needs of individual customers.

The lawsuit was over Teva's conduct in alleged price fixing in the US. Teva denies all wrongdoing.

Israeli institutional investors Harel, Migdal and Meitav-Dash were among the investors in the Israeli hydrogen and ammonia fuel cell solutions company.

The $400 million agreement has been signed with a shipping company that is affiliated with Kenon Holdings Ltd., controlled by Idan Ofer, Zim's largest shareholder.

The Teddy Sagi controlled company's revenue and EBITDA were substantially above its own forecasts.

Despite declaring that it was dealing purely with technology and not its planned $50 billion flotation, Mobileye was clearly running a roadshow.

Melcer retired as a Supreme Court judge last year. Eliahu, 86, holds 64% of Migdal Insurance and Financial Holdings.

The controlling shareholders will be required to inject $2 for every $3 that the state grants.